GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Well Pharmaceutical Group Co Ltd (SHSE:603351) » Definitions » Price-to-Funds-From-Operations

Nanjing Well Pharmaceutical Group Co (SHSE:603351) Price-to-Funds-From-Operations : (As of Dec. 12, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Nanjing Well Pharmaceutical Group Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Nanjing Well Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 99, Changfeng Hexi Road, Nanjing Chemical Industry Park, Jiangsu Province, Nanjing, CHN, 210000
Nanjing Well Pharmaceutical Group Co Ltd is engaged in research and development, production and sales of pharmaceutical auxiliary materials and synthetic lubricating base oil and other products. The company uses a variety of pharmaceutical dosage forms such as injection, oral administration and external use to guarantee the molding, effectiveness, stability and safety of pharmaceutical dosage forms.
Executives
Zou Jian Guo senior management
Wang Fu Qiu Directors, senior managers
Wu Rong Wen Supervisors